- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7276
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cancer neoantigens as potential targets for immunotherapy ; day:5 ; month:5 ; year:2021 ; pages:1-10
Clinical & experimental metastasis ; (5.5.2021), 1-10
- Creator
-
Ma, Weijie
Pham, Brian
Li, Tianhong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10585-021-10091-1
- URN
-
urn:nbn:de:101:1-2021090819421079031498
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ma, Weijie
- Pham, Brian
- Li, Tianhong
- SpringerLink (Online service)
Other Objects (12)
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy
Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy
Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
The Notch signaling pathway: a potential target for cancer immunotherapy
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2
p16INK4a as target for T cell-based cancer immunotherapy
Mutated neo-antigens as targets for individualized cancer immunotherapy
The complement system as a target in cancer immunotherapy
TOX as a potential target for immunotherapy in lymphocytic malignancies
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
Identification of novel immune checkpoints as targets for cancer immunotherapy